IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for ...

Improved education on drug toxicity management, especially within the first 90 days of treatment and regarding individualized ...

A nurse, foster mom and the primary provider for a family of eight, Shelly Sepulveda has devoted her life to taking care of ...

A new type of intensive chemotherapy is proving highly effective in treating women desperately ill with ovarian cancer, scientists announced today. The pioneering treatment is successful in 80% of ...

The Ovarian Cancer Research Alliance (OCRA) proudly announces the extraordinary success of its 2024 year-end fundraising campaign, surpassing its $2 million goal and marking a transformative milestone ...

A new pathway to fast track patients from the Preston area with suspected ovarian cancer is being implemented at the Royal ...

In a new study led by researchers at Karolinska Institutet in Sweden, AI models did a better job of detecting ovarian cancer ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).

Epithelial ovarian cancer is the fourth biggest cause of cancer-related death in women. Over recent decades, improvements have been made in treatment outcome in terms of response rate and survival.

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...